WEEK 6 6013:Understanding Psychiatric Comorbidities with Alcohol Use- VID 2

Aug 27, 2024

Lecture Notes: Psychiatric Comorbidities with Alcohol Use Disorder

Key Topics

  • Psychiatric Comorbidities
    • Mood and anxiety disorders co-occur frequently with substance use disorders.
    • Bi-directional relationship between mood/anxiety disorders and alcohol use.

Alcohol Use and Mood Disorders

  • Statistics from NIAAA Study:

    • 40% of individuals with alcohol use disorder have a current mood disorder.
    • 30% have a current anxiety disorder.
  • Bi-directional Relationship:

    • Alcohol can worsen depression and anxiety (alcohol as a depressant).
    • Mood disorders can lead to alcohol use as a form of self-medication.
    • Shared vulnerabilities such as genetic predispositions and early life adversities.

Treatment Challenges

  • Complicated Diagnosis:

    • Mood/anxiety symptoms can mimic alcohol use disorder symptoms.
    • Important to discern between independent and substance-induced disorders.
  • Diagnosis and Treatment:

    • Look at the order of symptom appearance and family history.
    • Anxiety disorders often pre-date substance use disorder.
    • Assess mood/anxiety symptoms during abstinence periods.

Treatment Strategies

  • Independent Disorders:

    • Target mood/anxiety disorders independently if they are primary.
  • Substance-Induced Disorders:

    • Focus on cessation or reduction of alcohol use.
  • Antidepressants and Psychosocial Treatments:

    • Antidepressants offer mild benefits for concurrent mood and substance disorders.
    • Psychosocial treatments (e.g., CBT) recommended for mild-moderate depression.
    • Severe depression may require early medication intervention.

Clinical Trials and Medications

  • Sertraline and Naltrexone Combination:

    • Combined treatment can outperform monotherapies in independent mood and alcohol disorders.
  • Medication Recommendations:

    • SSRIs like Sertraline have the most evidence base.
    • Patient preference and severity guide treatment start.
  • Anxiety Disorders:

    • Gabapentin as dual treatment for anxiety and alcohol use.
  • Benzodiazepines:

    • Not recommended for long-term treatment due to misuse potential.
    • Alternative medications include trazodone, anticonvulsants, and lifestyle changes.

Key Points

  • Assessment:

    • Clinicians need to assess if mood/anxiety symptoms are independent or substance-induced.
  • Treatment Initiation:

    • Psychosocial treatments first unless severe symptoms or patient preference.
    • Combine treatments for severe or persistent mood symptoms.
  • Medication Use:

    • Avoid simultaneous initiation of two medications unless necessary due to severity.